Transdermal delivery of hyaluronic acid - Human growth hormone conjugate

Biomaterials

Volumn 33, Issue 25, 2012, Pages 5947-5954

  Yang, Jeong A ^a   Kim, Eung Sam ^a   Kwon, Jung Hee ^a   Kim, Hyemin ^a   Shin, Ji Hye ^a   Yun, Seok Hyun ^b   Choi, Kwan Yong ^a   Hahn, Sei Kwang ^a,b  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Conjugate; Human growth hormone; Hyaluronic acid; Receptors; Transdermal delivery

Indexed keywords

CONJUGATE; HUMAN GROWTH HORMONE; HYALURONIC ACIDS; RECEPTORS; TRANSDERMAL DELIVERY;

ALDEHYDES; BIOACTIVITY; CELL CULTURE; FIBROBLASTS; FLUORESCENCE MICROSCOPY; ORGANIC ACIDS; PHOSPHORYLATION; TISSUE ENGINEERING;

TISSUE;

GROWTH HORMONE; HYALURONIC ACID; JANUS KINASE 2; SOMATOMEDIN C;

AREA UNDER THE CURVE; ARTICLE; CELL PROLIFERATION; CELL SURFACE; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG STABILITY; ENZYMATIC DEGRADATION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; KIDNEY CLEARANCE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ALDEHYDES; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; CHROMATOGRAPHY, GEL; DERMIS; DRUG DELIVERY SYSTEMS; HUMAN GROWTH HORMONE; HUMANS; HYALURONIC ACID; JANUS KINASE 2; MICE; MICROSCOPY, FLUORESCENCE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY;

MUS;

EID: 84862237051     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.05.003     Document Type: Article

References (30)

1. Prausnitz M.R., Mitragotri S., Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 2004, 3:115-124.
2. Prausnitz M.R., Langer R. Transdermal drug delivery. Nat Biotechnol 2008, 26:1261-1268.
3. Langer R. Transdermal drug delivery: past, progress, current status and future prospects. Adv Drug Deliv Rev 2004, 56:557-558.
4. Wu K.S., van Osdol W.W., Dauskardt R.H. Mechanical properties of human stratum corneum: effects of temperature, hydration, and chemical treatment. Biomaterials 2006, 27:785-795.
5. Sivamani R.K., Liepmann D., Maibach H.I. Microneedles and transdermal applications. Expert Opin Drug Deliv 2007, 4:19-25.
6. Wermeling D.P., Banks S.L., Hudson D.A., Gill H.S., Gupta J., Prausnitz M.R., et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci USA 2008, 105:2058-2063.
7. Kalia Y.N., Naik A., Garrison J., Guy R.H. Iontophoretic drug delivery. Adv Drug Deliv Rev 2004, 56:619-658.
8. Pikal M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev 2001, 46:281-305.
9. Williams A.C., Barry B.W. Penetration enhancer. Adv Drug Deliv Rev 2004, 56:603-618.
10. Karande P., Jain A., Mitragotri S. Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol 2004, 22:192-197.
11. Park E.J., Werner J., Smith N.B. Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer. Pharm Res 2007, 24:1396-1401.
12. Mitragotri S., Blankschtein D., Langer R. Ultrasound-mediated transdermal protein delivery. Science 1995, 269:850-853.
13. Laurent T.C., Fraser J.R. Hyaluronan. Faseb J 1992, 6:2397-2404.
14. Oh E.J., Park K., Kim K.S., Kim J., Yang J.A., Kong J.H., et al. Target specific and long acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J Control Release 2010, 141:2-12.
15. Juhlin L. Hyaluronan in skin. J Intern Med 1997, 242:61-66.
16. Brown T.J., Alcorn D., Fraser J.R.E. Absorption of hyaluronan applied to the surface of intact skin. J Invest Dermatol 1999, 113:740-746.
17. Brown M.B., Jones S.A. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. J Eur Acad Dermatol Venerol 2005, 19:308-318.
18. Wang C., Tammi M., Tammi R. Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 1992, 98:105-112.
19. Tammi R., Saamanen A.M., Maibach H.I., Tammi M. Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture. J Invest Dermatol 1991, 97:126-130.
20. Lokeshwar V.B., Iida N., Bourguignon L.Y.W. The cell adhesion molecule, GP116, is a new CD44 variant (ex14/v10) involved in hyaluronic acid binding and endothelial cell proliferation. J Biol Chem 1996, 271:23853-23864.
21. Ahrens T., Assmann V., Fieber C., Termeer C.C., Herrlich P., Hofmann M., et al. CD 44 is the principal mediator of hyaluronic acid induced melanoma cell proliferation. J Invest Dermatol 2001, 116:93-101.
22. Bourguignon L.Y.W., Singleton P.A., Diedrich F. Hyaluronan-CD44 interaction with Rac1-dependent protein kinase N-γ promotes phospholipase cγ1 activation, Ca2+ signaling, and cortactin-cytoskeleton function leading to keratinocyte adhesion and differentiation. J Biol Chem 2004, 279:29654-29669.
23. Masellis-Smith A., Belch A.R., Mant M.F., Turley E.A., Pilarski L.M. Hyaluronan dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood 1996, 87:1891-1899.
24. Yoneda M., Yamagata M., Suzuki S., Kimata K. Hyaluronic acid modulates proliferation of mouse dermal fibroblasts in culture. J Cell Sci 2004, 90:265-273.
25. Oakes S.R., Haynes K.M., Waters M.J., Herington A.C., Werther G.A. Demostration and localization of growth hormone receptor in human skin and skin fibroblasts. J Clin Endocrinol Metab 1992, 5:1368-1373.
26. Tavakkol A., Elder J.T., Griffiths C.E.M., Cooper K.D., Talwar H., Fisher G.J., et al. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol 1992, 99:343-349.
27. Cook J.J., Haynes K.M., Werther G.A. Mitogenic effects of growth hormone in cultured human fibroblasts-evidence for action via local insulin-like growth factor 1 production. J Clin Invest 1988, 81:206-212.
28. Yang J.A., Park K., Jung H.T., Kim H.M., Hong S.W., Yoon S.K., et al. Target specific hyaluronic acid-interferon alpha conjugate for the treatment of hepatitis C virus infection. Biomaterials 2011, 32:8722-8729.
29. Conway-Campbell B.L., Brooks A.J., Robinson P.J., Perani M., Waters M.J. The extracellular domain of the growth hormone receptor tnteracts with coactivator activator to promote cell proliferation. Mol Endocrinol 2008, 22:2190-2202.
30. Argetsinger L.S., Campbell G.S., Yang X., Witthuhn B.A., Silvennoinen O., Ihle J.N., et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 1993, 74:237-244.